Cost-effectiveness of extended release naltrexone to prevent relapse among criminal justice-involved individuals with a history of opioid use disorder
Gardado en:
Murphy, S.M., et al., Cost-effectiveness of extended release naltrexone to prevent relapse among criminal justice-involved individuals with a history of opioid use disorder. Addiction, vol. 112, n. 8, 2017, p. 1440-1450.
Ref.
526524
Localización:
SIIS Archivo (R.696)
Palabras clave:
Drogodependencias, Drogas ilegales, Opiáceos, Delincuencia, Tratamiento médico, Naltrexona, Efectos, Resultados, Calidad de vida, Análisis coste eficacia, Evaluación de servicios, EE.UU.
Drogodependencias, Drogas ilegales, Opiáceos, Delincuencia, Tratamiento médico, Naltrexona, Efectos, Resultados, Calidad de vida, Análisis coste eficacia, Evaluación de servicios, EE.UU.
Títulos similares: Cost-effectiveness of extended release naltrexone to prevent relapse among criminal justice-involved individuals with a history of opioid use disorder
- Interest in extended release naltrexone among opioid users
- Extended-release naltrexone for alcohol and opioid problems in missouri parolees and probationers
- Injectable extended-release naltrexone (XR-NTX) for opioid dependence: long-term safety and effectiveness
- Extended-release naltrexone for alcohol and opioid dependence: A meta-analysis of healthcare utilization studies
- EXTENDED-RELEASE NALTREXONE FOR TREATMENT OF ALCOHOL DEPENDENCE IN PRIMARY CARE
- Effect of extended-release naltrexone on alcohol consumption: a systematic review and meta-analysis